Gain Therapeutics News

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mack Gene

Apr 8 19:48 ET

Gain Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Mack Gene

Apr 8 19:43 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Riley Jeffrey Scott

Apr 1 16:03 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Alder Matthias

Mar 28 21:00 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fuggetta Gianluca

Mar 25 21:35 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Alder Matthias

Mar 25 21:35 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias

Dec 22, 2023 16:17 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias

Dec 14, 2023 16:01 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias

Oct 3, 2023 16:36 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RICHMAN ERIC I

Sep 22, 2023 16:34 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias

Sep 22, 2023 16:34 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Alder Matthias

Jul 5, 2023 16:18 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Islam Khalid

Jun 26, 2023 16:40 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Riley Jeffrey Scott

Jun 26, 2023 16:39 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDSTEIN DOV A MD

Jun 26, 2023 16:38 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Melincoff Gwen A

Jun 26, 2023 16:38 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude

Jun 26, 2023 16:37 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HASLER HANS PETER

Jun 26, 2023 16:36 ET

Gain Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Ballantyne Charles Evan

Apr 12, 2023 17:36 ET

Gain Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Ballantyne Charles Evan

Apr 12, 2023 17:35 ET